α-ANF(1-28), human
CAS No. 91917-63-4
α-ANF(1-28), human ( ——— )
产品货号. M41405 CAS No. 91917-63-4
Atrial natriuretic factor (1-28) (human, porcine) 是 pro-opiomelanocortin (POMC) mRNA 的强效抑制因子和βEP-LI释放的弱抑制因子。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称α-ANF(1-28), human
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Atrial natriuretic factor (1-28) (human, porcine) 是 pro-opiomelanocortin (POMC) mRNA 的强效抑制因子和βEP-LI释放的弱抑制因子。
-
产品描述Atrial natriuretic factor (1-28) (human, porcine) exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) increases cGMP levels in RMIC cells with an IC50 of 1.2 nM.
-
体外实验ANF-(1-28) (0.5 μg/kg/min) infusion attenuates the rise in plasma creatinine levels by approximately 50% on each day of the study.
-
体内实验ANF-(1-28) markedly increaseS guanosine 3',5'-cyclic monophosphate (cGMP) from 1.3 +/- 0.3 to 106 +/- 22 pmol cGMP/10(6) cells [50% effective dosage (ED50) = 1.2 nM].
-
同义词———
-
通路Others
-
靶点Other Targets
-
受体———
-
研究领域———
-
适应症———
化学信息
-
CAS Number91917-63-4
-
分子量3080.46
-
分子式C127H203N45O39S3
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. B M Fontoura, et al. Atrial natriuretic factor receptors in cultured renomedullary interstitial cells. Am J Physiol. 1990 Apr;258(4 Pt 1):C692-9.?
产品手册
关联产品
-
Bacitracin
杆菌肽是由枯草芽孢杆菌变种的地衣类生物体产生的相关环状多肽的混合物。
-
Peptide M
Peptide M is a synthetic Peptide, 50 aa, derived from streptococcus M protein, containing an additional c-terminal cysteine residue.
-
Damascenone
大马士酮是一种去甲异戊二烯酮,主要存在于红酒中。它天然存在于番茄和葡萄中。
021-51111890
购物车()
sales@molnova.cn

